Gemcitabine Plus Erlotinib for Advanced Pancreatic Cancer: A Systematic Review with Meta-Analysis

• Zu-Yao Yang,

  Affiliations Division of Epidemiology, The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China, The Hong Kong Branch of The Chinese Cochrane Centre, The Chinese University of Hong Kong, Hong Kong, China

  ⨯
• Jin-Qiu Yuan ,

  Contributed equally to this work with: Jin-Qiu Yuan, Meng-Yang Di

  Affiliation Division of Epidemiology, The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China

  ⨯
• Meng-Yang Di ,

  Contributed equally to this work with: Jin-Qiu Yuan, Meng-Yang Di

  Affiliation Division of Epidemiology, The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China

  ⨯
• Da-Yong Zheng,

  Affiliation Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China

  ⨯
• Jin-Zhang Chen,

  Affiliation Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China

  ⨯
• Hong Ding,

  Affiliation Department of Epidemiology, School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou, Guangdong Province, China

  ⨯
• Xin-Yin Wu,

  Affiliation Division of Epidemiology, The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China

  ⨯
• Ya-Fang Huang,

  Affiliation Division of Epidemiology, The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China

  ⨯
• Chen Mao ,

  * E-mail: maochen@cuhk.edu.hk (CM); jltang@cuhk.edu.hk (JLT)

  Affiliations Division of Epidemiology, The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China, The Hong Kong Branch of The Chinese Cochrane Centre, The Chinese University of Hong Kong, Hong Kong, China, Shenzhen Municipal Key Laboratory for Health Risk Analysis, Shenzhen Research Institute of The Chinese University of Hong Kong, Shenzhen, Guangdong Province, China

  ⨯
• Jin-Ling Tang

  * E-mail: maochen@cuhk.edu.hk (CM); jltang@cuhk.edu.hk (JLT)

  Affiliations Division of Epidemiology, The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China, The Hong Kong Branch of The Chinese Cochrane Centre, The Chinese University of Hong Kong, Hong Kong, China, Shenzhen Municipal Key Laboratory for Health Risk Analysis, Shenzhen Research Institute of The Chinese University of Hong Kong, Shenzhen, Guangdong Province, China

  ⨯